Explore the strategic benefits and revenue opportunities that await when you leverage licensing to maximize the value of your creations with Actuate IP law specialists. Discover how licensing can ...

Joel Masterson is a senior associate with Actuate IP, an experienced IP lawyer and a registered trademark attorney. He specialises in anti-counterfeiting litigation. During his career he has acted for ...

Colin Cheung is a founding partner at Actuate IP, an award-winning Australian IP practice. Based in Melbourne and Sydney, his firm services clients nationally and internationally. Mr Cheung has ...

IP ratings measure a device’s resistance to water, dust, and other particles, while military specs describe structural integrity. Some certifications are a little less precise than others ...

If you are experiencing trouble with your network connection and have it configured to DHCP, figuring out your IP address can be quite a task. Using a Static IP Address helps avert IP address ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage ...

How to find my IP address? — a question you might need to ask if you're doing any kind of networking in your home. Whether ...

This page features the latest news about the Actuate Therapeutics stock. Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development Companies will discuss how Lantern's AI ...

Companies will discuss how Lantern’s AI platform is being leveraged for the identification and development of enrichment biomarkers for Actuate’s lead investigational drug product ...

CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on ...